Loading clinical trials...
Loading clinical trials...
A Cluster Randomised Trial Comparing the Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence. The ARNS 12249 TasP (Treatment as Prevention) Trial in Hlabisa Sub-district, KwaZulu-Natal, South Africa.
Conditions
Interventions
Immediate ARV treatment initiation with TDF/FTC/EFV
South African recommendation guided ARV (TDF/FTC/EFV) initiation
Locations
1
South Africa
Hlabisa Hospital
Hlabisa, KwaZulu-Natal, South Africa
Start Date
March 1, 2012
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
July 21, 2016
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions